Investment
Features
FeesSafety
Academy
More
Pluang+

Compare UBC Medical Indonesia Tbk. (LABS) vs Sari Kreasi Boga Tbk. (RAFI) Price & Performance

UBC Medical Indonesia Tbk.Trade
Sari Kreasi Boga Tbk.Trade

Price performance (Past 24H)

Key statistics

UBC Medical Indonesia Tbk. vs Sari Kreasi Boga Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp174 (market cap 691.25B, 635.5K 24h volume), while Sari Kreasi Boga Tbk. trades at Rp36 (market cap 115.74B, 1.83M 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 6× Sari Kreasi Boga Tbk.'s market cap, and Sari Kreasi Boga Tbk. is more actively traded (1.83M versus 635.5K). Which is the better fit depends on your goals.

LABSRAFI
Market Cap
691.25B115.74B
Volume
635.5K1.83M
Lot
6.36K18.26K
Turnover
110.15M
Average Price
173.33
Value
110.15M
Indicative Equilibrium Price
174
Indicative Equilibrium Volume
50

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LABS
View details
RAFI
View details

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS

About Sari Kreasi Boga Tbk.

PT Sari Kreasi Boga Tbk (the Company) was established based on Deed No. 29 dated July 17, 2017 made before Notary Mahendra Adinegara, S.H., M.Kn. in Jakarta.

Read more on RAFI